Morocco continues to modernize its regulatory framework for medical research. A new decree published in the Official Bulletin on May 4, 2026, modifies and completes provisions governing biomedical research and clinical trials.
The decree aims to strengthen oversight of clinical trials, ensuring they meet international ethical and scientific standards. It updates requirements for informed consent, data protection, and trial monitoring.
This regulatory update aligns Morocco with global best practices in clinical research, potentially attracting more international studies to the country. The Ministry of Health has emphasized the importance of protecting participants while fostering innovation.
